232 related articles for article (PubMed ID: 25448357)
21. Glutathione-S-transferase activity in malarial parasites.
Srivastava P; Puri SK; Kamboj KK; Pandey VC
Trop Med Int Health; 1999 Apr; 4(4):251-4. PubMed ID: 10320651
[TBL] [Abstract][Full Text] [Related]
22. Effects of 5,8-dimethylthieno[2,3-b]quinoline-2-carboxylic acid on the antioxidative defense and lipid membranes in Plasmodium berghei-infected erythrocytes.
Gamboa de Domínguez ND; Charris J; Domínguez J; Monasterios M; Angel J; Rodrigues J
Exp Parasitol; 2015 Aug; 155():26-34. PubMed ID: 25956945
[TBL] [Abstract][Full Text] [Related]
23. In Vitro Activities of Primaquine-Schizonticide Combinations on Asexual Blood Stages and Gametocytes of Plasmodium falciparum.
Cabrera M; Cui L
Antimicrob Agents Chemother; 2015 Dec; 59(12):7650-6. PubMed ID: 26416869
[TBL] [Abstract][Full Text] [Related]
24. Glutathione and peroxide metabolism in malaria-parasitized erythrocytes.
Fritsch B; Dieckmann A; Menz B; Hempelmann E; Fritsch KG; Fritsch G; Jung A
Parasitol Res; 1987; 73(6):515-7. PubMed ID: 3321043
[TBL] [Abstract][Full Text] [Related]
25. Identification and bioinformatic characterization of a multidrug resistance associated protein (ABCC) gene in Plasmodium berghei.
González-Pons M; Szeto AC; González-Méndez R; Serrano AE
Malar J; 2009 Jan; 8():1. PubMed ID: 19118502
[TBL] [Abstract][Full Text] [Related]
26. [Studies on piperaquine as long-acting antimalarial drug against Plasmodium berghei in mice].
Zhu DQ; Dai ZR; Li JC; Jiang ZK
Yao Xue Xue Bao; 1982 Dec; 17(12):894-8. PubMed ID: 6763837
[No Abstract] [Full Text] [Related]
27. Molecular cloning, characterization and expression profile of a glutathione peroxidase-like thioredoxin peroxidase (TPxGl) of the rodent malaria parasite Plasmodium berghei.
Haselton KJ; David R; Fell K; Schulte E; Dybas M; Olsen KW; Kanzok SM
Parasitol Int; 2015 Jun; 64(3):282-9. PubMed ID: 24637102
[TBL] [Abstract][Full Text] [Related]
28. Piperaquine pharmacodynamics and parasite viability in a murine malaria model.
Moore BR; Ilett KF; Page-Sharp M; Jago JD; Batty KT
Antimicrob Agents Chemother; 2009 Jul; 53(7):2707-13. PubMed ID: 19380600
[TBL] [Abstract][Full Text] [Related]
29. Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum.
Friebolin W; Jannack B; Wenzel N; Furrer J; Oeser T; Sanchez CP; Lanzer M; Yardley V; Becker K; Davioud-Charvet E
J Med Chem; 2008 Mar; 51(5):1260-77. PubMed ID: 18260613
[TBL] [Abstract][Full Text] [Related]
30. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives.
Vijayaraghavan S; Mahajan S
Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947
[TBL] [Abstract][Full Text] [Related]
31. Recent studies on antimalarial efficacy of piperaquine and hydroxypiperaquine.
Chen L
Chin Med J (Engl); 1991 Feb; 104(2):161-3. PubMed ID: 1874015
[TBL] [Abstract][Full Text] [Related]
32. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
Biot C; Dessolin J; Grellier P; Davioud-Charvet E
Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365
[TBL] [Abstract][Full Text] [Related]
33. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
[TBL] [Abstract][Full Text] [Related]
34. [Malaria parasite DNA and RNA changes connected with acquired resistance to chloroquine].
Pankova TG; Igonina TM; Maĭer TV; Salganik RI
Mol Biol (Mosk); 1996; 30(1):43-50. PubMed ID: 8714121
[No Abstract] [Full Text] [Related]
35. Implication of intracellular glutathione and its related enzymes on resistance of malaria parasites to the antimalarial drug arteether.
Chandra R; Tripathi LM; Saxena JK; Puri SK
Parasitol Int; 2011 Jan; 60(1):97-100. PubMed ID: 20971213
[TBL] [Abstract][Full Text] [Related]
36. Plasmodium berghei: identification of an mdr-like gene associated with drug resistance.
Gervais GW; Trujillo K; Robinson BL; Peters W; Serrano AE
Exp Parasitol; 1999 Jan; 91(1):86-92. PubMed ID: 9920046
[TBL] [Abstract][Full Text] [Related]
37. Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity.
Parashar D; Aditya NP; Murthy RS
Drug Deliv; 2016; 23(1):123-9. PubMed ID: 24786480
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of the antimalarial action of chloroquine in rodent malaria by drugs known to reduce cellular glutathione levels.
Deharo E; Barkan D; Krugliak M; Golenser J; Ginsburg H
Biochem Pharmacol; 2003 Sep; 66(5):809-17. PubMed ID: 12948862
[TBL] [Abstract][Full Text] [Related]
39. Exploring the antimalarial potential of whole Cymbopogon citratus plant therapy.
Chukwuocha UM; Fernández-Rivera O; Legorreta-Herrera M
J Ethnopharmacol; 2016 Dec; 193():517-523. PubMed ID: 27693771
[TBL] [Abstract][Full Text] [Related]
40. Vital and dispensable roles of Plasmodium multidrug resistance transporters during blood- and mosquito-stage development.
Rijpma SR; van der Velden M; Annoura T; Matz JM; Kenthirapalan S; Kooij TW; Matuschewski K; van Gemert GJ; van de Vegte-Bolmer M; Siebelink-Stoter R; Graumans W; Ramesar J; Klop O; Russel FG; Sauerwein RW; Janse CJ; Franke-Fayard BM; Koenderink JB
Mol Microbiol; 2016 Jul; 101(1):78-91. PubMed ID: 26991313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
